These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31223062)

  • 21. Gene invasion in distant eukaryotic lineages: discovery of mutually exclusive genetic elements reveals marine biodiversity.
    Monier A; Sudek S; Fast NM; Worden AZ
    ISME J; 2013 Sep; 7(9):1764-74. PubMed ID: 23635865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inteins as Drug Targets and Therapeutic Tools.
    Tharappel AM; Li Z; Li H
    Front Mol Biosci; 2022; 9():821146. PubMed ID: 35211511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inteins in pathogenic fungi: a phylogenetic tool and perspectives for therapeutic applications.
    Theodoro RC; Bagagli E
    Mem Inst Oswaldo Cruz; 2009 May; 104(3):497-504. PubMed ID: 19547879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with Recombinant
    Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of de Novo Adenosine Triphosphate (ATP) Biosynthesis Abolishes Virulence in Cryptococcus neoformans.
    Blundell RD; Williams SJ; Arras SD; Chitty JL; Blake KL; Ericsson DJ; Tibrewal N; Rohr J; Koh YQ; Kappler U; Robertson AA; Butler MS; Cooper MA; Kobe B; Fraser JA
    ACS Infect Dis; 2016 Sep; 2(9):651-663. PubMed ID: 27759389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Small Protein Associated with Fungal Energy Metabolism Affects the Virulence of Cryptococcus neoformans in Mammals.
    McClelland EE; Ramagopal UA; Rivera J; Cox J; Nakouzi A; Prabu MM; Almo SC; Casadevall A
    PLoS Pathog; 2016 Sep; 12(9):e1005849. PubMed ID: 27583447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Puf4 Mediates Post-transcriptional Regulation of Cell Wall Biosynthesis and Caspofungin Resistance in Cryptococcus neoformans.
    Kalem MC; Subbiah H; Leipheimer J; Glazier VE; Panepinto JC
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual mating of Botrytis cinerea illustrates PRP8 intein HEG activity.
    Bokor AA; van Kan JA; Poulter RT
    Fungal Genet Biol; 2010 Apr; 47(4):392-8. PubMed ID: 20093192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino Acid Permeases and Virulence in Cryptococcus neoformans.
    Martho KF; de Melo AT; Takahashi JP; Guerra JM; Santos DC; Purisco SU; Melhem MS; Fazioli RD; Phanord C; Sartorelli P; Vallim MA; Pascon RC
    PLoS One; 2016; 11(10):e0163919. PubMed ID: 27695080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular docking and MD simulations reveal protease inhibitors block the catalytic residues in Prp8 intein of
    Panda S; Rout M; Mishra S; Turuk J; Pati S; Dehury B
    J Biomol Struct Dyn; 2023 Dec; ():1-16. PubMed ID: 38149850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
    Paul S; Doering TL; Moye-Rowley WS
    Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
    Chayakulkeeree M; Tangkoskul T; Waywa D; Tiengrim S; Pati N; Thamlikitkul V
    J Mycol Med; 2020 Apr; 30(1):100905. PubMed ID: 31706700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Novel J-Domain Protein Mrj1 Is Required for Mitochondrial Respiration and Virulence in Cryptococcus neoformans.
    Horianopoulos LC; Hu G; Caza M; Schmitt K; Overby P; Johnson JD; Valerius O; Braus GH; Kronstad JW
    mBio; 2020 Jun; 11(3):. PubMed ID: 32518190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRP8 intein in dermatophytes: Evolution and species identification.
    Garcia Garces H; Cordeiro RT; Bagagli E
    Med Mycol; 2018 Aug; 56(6):746-758. PubMed ID: 29228309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
    Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.